OLEMA PHARMACEUTICALS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9.95 USD | +1.22% |
|
+0.20% | -29.08% |
| 02/04 | Goldman Sachs Initiates Olema Pharmaceuticals at Buy With $24 Price Target | MT |
| 18/03 | Olema Pharmaceuticals, Inc.(NasdaqGS:OLMA) added to S&P Biotechnology Select Industry Index | CI |
Chart calendar Olema Pharmaceuticals, Inc.
a062a6e81255a1ec336.Ut3QUwLaQUNB6fomax6VvFlcpR-9i4sTj0buCy9lbg8.HJuAHEiQcSU73YleGHKl1yw9yGnzuO8i-3-gWU4TIW4Kh7g_T7QMEXWwlQ~5949d4db79d57d44ec17d473f942b8f6
Upcoming events on Olema Pharmaceuticals, Inc.
Past events on Olema Pharmaceuticals, Inc.
| 15/04/2024 11:30 pm | CG Horizons in Oncology Virtual Conference - Panel |
| 12/03/2024 | Jefferies Biotech on the Bay Summit |
| 12/03/2024 01:33 am | Q4 2023 Earnings Release |
| 06/03/2024 07:40 pm | TD Cowen Health Care Conference - Panel |
| 13/02/2024 09:10 pm | Oppenheimer Healthcare Life Sciences Conference |
| 10/01/2024 06:45 am | JPMorgan Healthcare Conference |
| 08/12/2023 05:00 am | San Antonio Breast Cancer Symposium - PS15-04 |
| 08/12/2023 04:30 am | San Antonio Breast Cancer Symposium - PO4-04-12 |
| 07/12/2023 11:30 pm | San Antonio Breast Cancer Symposium - PO3-18-09 |
| 06/12/2023 06:30 pm | Business Update Call |
| 29/11/2023 11:50 pm | Evercore ISI HealthCONx Conference |
| 15/11/2023 06:00 pm | Jefferies London Healthcare Conference |
| 08/11/2023 02:32 am | Q3 2023 Earnings Release |
| 23/10/2023 05:30 pm | European Society for Medical Oncology Congress |
| 22/10/2023 12:25 pm | European Society for Medical Oncology Congress - Presentation #:382MO |
| 12/10/2023 10:00 pm | AACR-NCI-EORTC International Conference - Abstract Number : A044 |
| 28/09/2023 01:40 am | Cantor Global Healthcare Conference |
| 12/09/2023 08:00 pm | H.C. Wainwright Global Investment Conference |
| 11/09/2023 08:10 pm | Morgan Stanley Global Healthcare Conference |
| 09/08/2023 11:30 pm | Canaccord Genuity Growth Conference |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 | -21,5 -16,9 -27.34% | -71,3 -71,0 -0.46% | -107 -124 14.01% | -105 -98,8 -5.83% | -140 |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -21,5 -18,5 -16.58% | -71,5 -67,2 -6.42% | -107 -106 -0.77% | -105 -100 -4.78% | -138 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -22,1 -19,9 -11.44% | -71,1 -66,8 -6.37% | -105 -105 -0.26% | -96,7 -94,1 -2.73% | -134 |
|
Net income Million USD | Released Forecast Spread | -4,32 | -24,0 -19,1 -25.84% | -71,1 -66,8 -6.37% | -105 -105 0.02% | -96,7 -94,0 -2.78% | -134 |
|
EPS USD | Released Forecast Spread | -0,60 | -3,42 -1,01 -237.85% | -1,80 -1,68 -7.14% | -2,62 -2,67 1.92% | -2,14 -2,12 -1.1% | -2,42 |
| Announcement Date | 30/10/20 | 17/03/21 | 28/02/22 | 09/03/23 | 11/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | -21,7 -21,0 -3.26% | -23,2 -26,0 10.88% | -33,2 -28,0 -18.6% | -23,1 -35,0 33.91% | -27,1 -24,0 -13.01% | -29,5 -28,0 -5.36% | -21,5 -30,0 28.33% | -23,3 -22,0 -5.69% | -30,3 -24,2 -25.33% | -31,9 | -33,2 | -35,5 | -39,9 |
|
EBIT Million USD | Released Forecast Spread | -21,8 -20,5 -6.03% | -23,3 -23,2 -0.34% | -33,3 -26,5 -25.87% | -23,2 -31,0 25.14% | -27,2 -26,3 -3.49% | -29,6 -27,1 -9.09% | -21,6 -30,0 28.09% | -23,3 -23,1 -0.95% | -30,4 -25,6 -18.77% | -31,3 | -33,5 | -36,0 | -38,7 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -21,6 -20,6 -5.24% | -23,0 -22,9 -0.57% | -32,9 -26,2 -25.65% | -22,7 -30,9 26.57% | -26,2 -26,0 -0.53% | -28,3 -26,8 -5.39% | -20,1 -29,4 31.6% | -21,5 -21,7 1.13% | -26,8 -24,2 -10.67% | -29,9 | -32,1 | -34,6 | -37,7 |
|
Net income Million USD | Released Forecast Spread | -21,6 -20,6 -5.24% | -23,0 -22,9 -0.57% | -32,9 -26,2 -25.65% | -22,7 -30,9 26.57% | -26,2 -26,0 -0.53% | -28,3 -26,8 -5.39% | -20,1 -29,8 32.63% | -21,5 -21,7 1.13% | -26,8 -24,2 -10.67% | -29,9 | -32,1 | -34,6 | -37,7 |
|
EPS USD | Released Forecast Spread | -0,54 -0,50 -9.09% | -0,58 -0,57 -1.8% | -0,82 -0,64 -27.55% | -0,57 -0,77 25.88% | -0,65 -0,65 0.4% | -0,70 -0,66 -5.6% | -0,49 -0,74 33.62% | -0,48 -0,51 6.18% | -0,49 -0,48 -1.98% | -0,54 | -0,58 | -0,62 | -0,68 |
| Announcement Date | 28/02/22 | 09/05/22 | 09/08/22 | 08/11/22 | 09/03/23 | 09/05/23 | 08/08/23 | 07/11/23 | 11/03/24 | - | - | - | - |
More events
Past sector events for Olema Pharmaceuticals, Inc.
| 27/04/2024 | GEMPHARMATECH CO., LTD.: Q1 2024 Earnings Release |
| 27/04/2024 | GEMPHARMATECH CO., LTD.: Q4 2023 Earnings Release |
| 26/04/2024 10:30 am | BB BIOTECH AG: Q1 2024 Earnings Release |
| 26/04/2024 | BIDE PHARMATECH CO., LTD.: Q4 2023 Earnings Release |
| 26/04/2024 | PHARMARESOURCES (SHANGHAI) CO., LTD.: Q1 2024 Earnings Release |
| 26/04/2024 | HINOVA PHARMACEUTICALS INC.: Q1 2024 Earnings Release (Projected) |
| 26/04/2024 | BEIJING SUN-NOVO PHARMACEUTICAL RESEARCH CO., LTD.: Q4 2023 Earnings Release |
| 26/04/2024 | CHEMPARTNER PHARMATECH CO., LTD.: Q4 2023 Earnings Release |
| 25/04/2024 04:30 pm | MORPHIC HOLDING, INC.: Q1 2024 Earnings Release |
| 25/04/2024 11:30 am | PURETECH HEALTH PLC: Q4 2023 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- OLMA Stock
- Calendar Olema Pharmaceuticals, Inc.
